{
  "openalex_id": "W2778229540",
  "doi": "https://doi.org/10.18632/oncotarget.23571",
  "title": "CD10-positive mantle cell lymphoma: clinicopathologic and prognostic study of 30 cases",
  "abstract": "// Jie Xu 1 , L. Jeffrey Medeiros 1 , Annapurna Saksena 1 , Michael Wang 2 , Jiehao Zhou 3 , Jingyi Li 1, 4 , C. Cameron Yin 1 , Guilin Tang 1 , Lifu Wang 1, 5 , Pei Lin 1 and Shaoying Li 1 1 Department of Hematopathology, UT MD Anderson Cancer Center, Houston, TX, USA 2 Department of Lymphoma and Myeloma, UT MD Anderson Cancer Center, Houston, TX, USA 3 Department of Pathology, Indiana University, Indianapolis, IN, USA 4 Department of Hematology, Tianjin First Center Hospital, China 5 Department of Pathology, Henan Provincial People's Hospital, Zhengzhou, Henan, China Correspondence to: Shaoying Li, email: sli6@mdanderson.org Keywords: CD10; mantle cell lymphoma; pathology; prognosis Received: August 18, 2017&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accepted: October 13, 2017&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Published: December 15, 2017 ABSTRACT Mantle cell lymphoma is usually negative for CD10 which is useful in distinguishing MCL from other CD10 + B cell lymphomas. Here we assessed the clinicopathologic features of 30 cases of CD10+ MCL, the largest series to date in the English literature, and compared them with a group of 212 typical MCL cases (CD5+, CD10-negative, CD23-negative, cyclin D1+). The 30 patients with CD10+ MCL included 17 men and 13 women with a median age of 68 years. Compared with CD10-negative MCL, patients with CD10+ MCL showed a lower male predominance ( p = 0.01), more often had a diffuse growth pattern ( p = 0.04) and blastoid/pleomorphic morphology ( p &lt; 0.0001), and more often showed BCL6 expression ( p = 0.009). In all MCL patients, CD10 expression was not associated with overall survival (OS) ( p = 0.16). However, in more aggressive subsets of MCL patients including those with high Ki67 (&gt; 60%), blastoid/pleomorphic morphology, or high MCL International Prognostic Index (MIPI), CD10 expression was associated with a worse OS ( p = 0.003, 0.04, and 0.001, respectively). High Ki67 (&gt; 60%), blastoid/pleomorphic morphology, and high MIPI were also been identified as poor prognostic factors patients with in CD10+ MCL ( p = 0.001, 0.0003, and 0.01, respectively). In summary, CD10+ MCL more often has a diffuse growth pattern, blastoid/pleomorphic morphology, and BCL6 expression. In MCL patients with a high Ki-67 (&gt; 60%), blastoid/pleomorphic morphology, or high MIPI, CD10 expression contributes to an even worse prognosis. MCL should be included in the differential diagnosis of CD10 + B cell lymphomas.",
  "authors": [
    {
      "display_name": "Jie Xu",
      "id": "A5100784495",
      "orcid": "https://orcid.org/0000-0001-9163-3898",
      "institutions": [
        {
          "id": "I1343551460",
          "display_name": "The University of Texas MD Anderson Cancer Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Jie Xu"
    },
    {
      "display_name": "L. Jeffrey Medeiros",
      "id": "A5000027373",
      "orcid": "https://orcid.org/0000-0001-6577-8006",
      "institutions": [
        {
          "id": "I1343551460",
          "display_name": "The University of Texas MD Anderson Cancer Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "L. Jeffrey Medeiros"
    },
    {
      "display_name": "Annapurna Saksena",
      "id": "A5046180000",
      "orcid": null,
      "institutions": [
        {
          "id": "I1343551460",
          "display_name": "The University of Texas MD Anderson Cancer Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Annapurna Saksena"
    },
    {
      "display_name": "Michael Wang",
      "id": "A5100438316",
      "orcid": "https://orcid.org/0000-0001-9748-5486",
      "institutions": [
        {
          "id": "I1343551460",
          "display_name": "The University of Texas MD Anderson Cancer Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Michael Wang"
    },
    {
      "display_name": "Jiehao Zhou",
      "id": "A5102872372",
      "orcid": "https://orcid.org/0000-0002-5635-4364",
      "institutions": [
        {
          "id": "I55769427",
          "display_name": "Indiana University â€“ Purdue University Indianapolis",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Jiehao Zhou"
    },
    {
      "display_name": "Jingyi Li",
      "id": "A5100399433",
      "orcid": "https://orcid.org/0009-0004-8823-7658",
      "institutions": [
        {
          "id": "I1343551460",
          "display_name": "The University of Texas MD Anderson Cancer Center",
          "country_code": "US",
          "type": "healthcare"
        },
        {
          "id": "I2800200322",
          "display_name": "Tianjin First Center Hospital",
          "country_code": "CN",
          "type": "healthcare"
        },
        {
          "id": "I5740404",
          "display_name": "Tianjin Medical University",
          "country_code": "CN",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Jingyi Li"
    },
    {
      "display_name": "C. Cameron Yin",
      "id": "A5006583715",
      "orcid": "https://orcid.org/0000-0001-6630-4128",
      "institutions": [
        {
          "id": "I1343551460",
          "display_name": "The University of Texas MD Anderson Cancer Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "C. Cameron Yin"
    },
    {
      "display_name": "Guilin Tang",
      "id": "A5055404021",
      "orcid": "https://orcid.org/0000-0002-9482-4806",
      "institutions": [
        {
          "id": "I1343551460",
          "display_name": "The University of Texas MD Anderson Cancer Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Guilin Tang"
    },
    {
      "display_name": "Lifu Wang",
      "id": "A5101922066",
      "orcid": "https://orcid.org/0000-0001-5172-9932",
      "institutions": [
        {
          "id": "I1343551460",
          "display_name": "The University of Texas MD Anderson Cancer Center",
          "country_code": "US",
          "type": "healthcare"
        },
        {
          "id": "I4210133534",
          "display_name": "Henan Provincial People's Hospital",
          "country_code": "CN",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Lifu Wang"
    },
    {
      "display_name": "Pei Lin",
      "id": "A5100439449",
      "orcid": "https://orcid.org/0000-0002-9844-945X",
      "institutions": [
        {
          "id": "I1343551460",
          "display_name": "The University of Texas MD Anderson Cancer Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Pei Lin"
    },
    {
      "display_name": "Shaoying Li",
      "id": "A5101659644",
      "orcid": "https://orcid.org/0000-0002-6857-0523",
      "institutions": [
        {
          "id": "I1343551460",
          "display_name": "The University of Texas MD Anderson Cancer Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Shaoying Li"
    }
  ],
  "publication_year": 2017,
  "publication_date": "2017-12-15",
  "type": "article",
  "cited_by_count": 31,
  "is_retracted": false,
  "is_paratext": false,
  "language": "en",
  "source": {
    "id": "S126644158",
    "display_name": "Oncotarget",
    "issn_l": "1949-2553",
    "issn": [
      "1949-2553"
    ],
    "type": "journal",
    "host_organization": "https://openalex.org/P4310316297"
  },
  "volume": "9",
  "issue": "14",
  "first_page": "11441",
  "last_page": "11450",
  "open_access": {
    "is_oa": true,
    "oa_status": "gold",
    "oa_url": "https://www.oncotarget.com/article/23571/pdf/",
    "any_repository_has_fulltext": true
  },
  "concepts": [
    {
      "id": "C2779060813",
      "display_name": "Hematopathology",
      "level": 5,
      "score": 0.73866284
    },
    {
      "id": "C2777537477",
      "display_name": "BCL6",
      "level": 5,
      "score": 0.7317873
    },
    {
      "id": "C2777525834",
      "display_name": "Mantle cell lymphoma",
      "level": 3,
      "score": 0.73050994
    },
    {
      "id": "C71924100",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.640582
    },
    {
      "id": "C199835354",
      "display_name": "Cyclin D1",
      "level": 4,
      "score": 0.5587606
    },
    {
      "id": "C126322002",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.5442907
    },
    {
      "id": "C2779338263",
      "display_name": "Lymphoma",
      "level": 2,
      "score": 0.47853455
    },
    {
      "id": "C143998085",
      "display_name": "Oncology",
      "level": 1,
      "score": 0.348714
    },
    {
      "id": "C142724271",
      "display_name": "Pathology",
      "level": 1,
      "score": 0.33131558
    },
    {
      "id": "C121608353",
      "display_name": "Cancer",
      "level": 2,
      "score": 0.32298252
    },
    {
      "id": "C2778453870",
      "display_name": "B cell",
      "level": 3,
      "score": 0.17048627
    },
    {
      "id": "C203014093",
      "display_name": "Immunology",
      "level": 1,
      "score": 0.13659534
    },
    {
      "id": "C185592680",
      "display_name": "Chemistry",
      "level": 0,
      "score": 0.08770877
    },
    {
      "id": "C174475383",
      "display_name": "Cytogenetics",
      "level": 4,
      "score": 0.08355692
    },
    {
      "id": "C159654299",
      "display_name": "Antibody",
      "level": 2,
      "score": 0.07892504
    },
    {
      "id": "C96926380",
      "display_name": "Germinal center",
      "level": 4,
      "score": 0.0
    },
    {
      "id": "C29537977",
      "display_name": "Cell cycle",
      "level": 3,
      "score": 0.0
    },
    {
      "id": "C55493867",
      "display_name": "Biochemistry",
      "level": 1,
      "score": 0.0
    },
    {
      "id": "C30481170",
      "display_name": "Chromosome",
      "level": 3,
      "score": 0.0
    },
    {
      "id": "C104317684",
      "display_name": "Gene",
      "level": 2,
      "score": 0.0
    }
  ],
  "topics": [
    {
      "id": "T10185",
      "display_name": "Lymphoma Diagnosis and Treatment",
      "score": 1.0
    },
    {
      "id": "T10685",
      "display_name": "Viral-associated cancers and disorders",
      "score": 0.9992
    },
    {
      "id": "T11157",
      "display_name": "Chronic Lymphocytic Leukemia Research",
      "score": 0.9987
    }
  ],
  "created_date": null,
  "updated_date": null,
  "indexed_in": [],
  "landing_page_url": "https://doi.org/10.18632/oncotarget.23571",
  "pdf_url": "https://www.oncotarget.com/article/23571/pdf/",
  "retrieved_date": "2025-07-30T15:58:50.587442",
  "source_database": "OpenAlex"
}